Cite
Retraction Note: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection.
MLA
Gunaseelan, Saravanan, et al. “Retraction Note: Pharmacological Perturbation of CXCL1 Signaling Alleviates Neuropathogenesis in a Model of HEVA71 Infection.” Nature Communications, vol. 14, no. 1, Feb. 2023, p. 1053. EBSCOhost, https://doi.org/10.1038/s41467-023-36751-2.
APA
Gunaseelan, S., Ariffin, M. Z., Khanna, S., Ooi, M. H., Perera, D., Chu, J. J. H., & Chua, J. J. E. (2023). Retraction Note: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection. Nature Communications, 14(1), 1053. https://doi.org/10.1038/s41467-023-36751-2
Chicago
Gunaseelan, Saravanan, Mohammed Zacky Ariffin, Sanjay Khanna, Mong How Ooi, David Perera, Justin Jang Hann Chu, and John Jia En Chua. 2023. “Retraction Note: Pharmacological Perturbation of CXCL1 Signaling Alleviates Neuropathogenesis in a Model of HEVA71 Infection.” Nature Communications 14 (1): 1053. doi:10.1038/s41467-023-36751-2.